Dresser Rebecca
School of Law, Program in Medicine and the Humanities, Washington University, One Brookings Drive, Box 1120, St. Louis, MO 63130, USA.
Theor Med Bioeth. 2006;27(2):115-39. doi: 10.1007/s11017-005-5289-5.
Pharmaceutical companies are major sponsors of biomedical research. Most scholars and policymakers focus their attention on government and academic oversight activities, however. In this article, I consider the role of pharmaceutical companies' internal ethics statements in guiding decisions about corporate research and development (R&D). I review materials from drug company websites and contributions from the business and medical ethics literature that address ethical responsibilities of businesses in general and pharmaceutical companies in particular. I discuss positive and negative uses of pharmaceutical companies' ethics materials and describe shortcomings in the companies' existing ethics programs. To guide employees and reassure outsiders, companies must add rigor, independence, and transparency to their R&D ethics programs.
制药公司是生物医学研究的主要赞助商。然而，大多数学者和政策制定者将注意力集中在政府和学术监督活动上。在本文中，我探讨了制药公司内部道德声明在指导企业研发决策方面的作用。我回顾了制药公司网站上的资料以及商业和医学伦理文献中关于企业，特别是制药公司道德责任的论述。我讨论了制药公司道德材料的积极和消极用途，并描述了公司现有道德计划中的不足之处。为了指导员工并安抚外部人士，公司必须在其研发道德计划中增加严谨性、独立性和透明度。
